Week 96 Resistance Analyses of the Once-Daily, Single-Tablet Regimen (STR) Darunavir/cobicistat/emtricitabine/tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase 3 Randomized AMBER and EMERALD Trials.
Journal of medical virology（2021）
关键词
archived RAMs,darunavir,cobicistat,emtricitabine,TAF,deep sequencing,efficacy,resistance,single‐,tablet regimen
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要